Physician profile
Laura White
NPI 1992465645
$2,119.83
in general payments reported to CMS, 2019-2025
21 companies · $851 in 2025
The $851 reported for 2025 was more than what 94% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $122 · 2023: $654 · 2024: $493 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,997.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $338.79 | 2022-2025 | |
| Biogen, INC. | $323.26 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $300.98 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $189.10 | 2023-2025 | Myfembree, Gemtesa |
| Evofem Biosciences, INC. | $152.17 | 2024-2025 | Solosec, Phexx, Phexxi |
| Exeltis, USA INC. | $103.97 | 2023-2025 | Slynd |
| Abbvie INC. | $101.98 | 2022-2023 | |
| Myriad Women'S Health, INC. | $91.31 | 2023 | |
| Novo Nordisk INC | $78.17 | 2023-2025 | Wegovy |
| Pfizer INC. | $77.58 | 2023-2025 | |
| Exact Sciences Corporation | $62.11 | 2023-2025 | Cologuard Collection Kit |
| Organon LLC | $60.75 | 2024-2025 | Nexplanon |
| Astellas Pharma US INC | $46.83 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $35.05 | 2022-2025 | Thinprep 2000 Processor, Aptima |
| Myovant Sciences INC. | $32.11 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $28.39 | 2023 | Dermabond Prineo |
| Vertex Pharmaceuticals Incorporated | $24.99 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.83 | 2022 | |
| Sanofi Pasteur INC. | $18.71 | 2025 | |
| Lilly USA, LLC | $16.03 | 2024 | Zepbound |
| Avion Pharmaceuticals | $14.72 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.